Pfizer Announces Positive Top-Line Results Of Landmark Community-Acquired Pneumonia Immunization Trial In Adults (CAPiTA) Evaluating Efficacy Of Prevenar 13*

[Business Wire] – Pfizer Inc. today announced that the Community-Acquired Pneumonia Immunization Trial in Adults , the landmark study of approximately 85,000 subjects evaluating the efficacy of Prevenar 13* in adults 65 years of age and older, achieved i more

View todays social media effects on PFE

View the latest stocks trending across Twitter. Click to view dashboard

See who Pfizer is hiring next, click here to view